FDA panel meeting to discuss RSV vaccine for infants

An FDA panel is meeting Thursday to discuss whether a new vaccine to protect infants from RSV is safe and effective. If it gets the green light, the shot would be the first of its kind given to pregnant women. Stephanie Stahl reports for CBS2.